SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cytokinetics, Inc. Announces Opening of Second Cohort in Phase IIb Clinical Trial of Intravenous Omecamtiv Mecarbil in Patients With Acute Heart Failure